A Novel Bisphosphonate-EP4a Conjugate Drug (C3) for Reversing Postmenopausal Osteoporotic Bone Loss.

Zeeshan Sheikh
Post-Doctoral Fellow, *Faculty of Dentistry, University of Toronto, *Lunenfeld Tanenbaum Research Institute, Mt. Sinai Hospital, Toronto, *Department of Laboratory Medicine & Pathobiology, Faculty of Medicine, University of Toronto
Monday, January 22, 2018 - 11:00am
Fitzgerald Building, Room #237
Research Group Seminar
Matrix Dynamics Group Seminar